Financials
- Market Capitalization 22.99 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
15.41
Fiyat/satışlar oranı
3.86
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 519 | ROIV Roivant Sciences Ltd. - Common Shares | 35.00 USD | +1.42% | -2.40% | +16.43% | +91.15% | 25.17 B USD | ||
| 537 | INSM Insmed Incorporated - Common Stock | 109.29 USD | +0.14% | -3.27% | +10.68% | -32.56% | 23.69 B USD | ||
| 564 | UTHR United Therapeutics Corporation - Common Stock | 527.31 USD | -1.54% | -5.49% | -3.42% | +77.13% | 22.38 B USD | ||
| 572 | BNTX BioNTech SE - American Depositary Shares | 90.58 USD | +0.57% | -3.72% | -0.69% | -18.40% | 21.74 B USD |